At Axela, we create tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing. Our systems are built upon advanced flow-through technologies that enable rapid, high performance nucleic acid and protein analysis. We provide easy to use, automated platforms that accelerate the transition of biomarker discoveries from the research laboratory to the clinic. Proprietary technology and manufacturing processes enable economical multiplex testing in both reference lab and point of use formats. Best in class sensitivity, time to result and small sample requirements bring value to partners developing products in infectious disease, oncology, immunology, allergy and specialty applications such as traumatic brain injury.